MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
Log in

NASDAQ:BOLDAudentes Therapeutics Earnings Date, Estimates & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
$59.97
0.00 (0.00 %)
(As of 01/15/2020)
Add
Compare
Today's Range
$59.97
Now: $59.97
$59.97
50-Day Range
$59.97
MA: $59.97
$59.97
52-Week Range
$22.00
Now: $59.97
$60.00
VolumeN/A
Average Volume1.50 million shs
Market Capitalization$2.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.18

Earnings

Audentes Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Audentes Therapeutics (NASDAQ:BOLD) Earnings Estimates

2020 EPS Consensus Estimate: ($4.37)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20204($1.19)($0.91)($1.06)
Q2 20204($1.24)($0.93)($1.10)
Q3 20204($1.28)($0.97)($1.10)
Q4 20204($1.34)($0.93)($1.11)
Q1 20211($1.07)($1.07)($1.07)
Q2 20211($1.01)($1.01)($1.01)
Q3 20211($0.61)($0.61)($0.61)

Audentes Therapeutics (NASDAQ BOLD) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/7/2019Q3($1.07)($1.00)($1.00)Transcript
8/6/2019Q2 2019($1.08)($1.01)($1.01)Listen
5/7/20193/31/2019($0.90)($1.13)($1.13)Listen
2/27/2019Q4 2018($0.92)($0.84)($0.84)Listen
11/6/20189/30/2018($0.88)($0.97)($0.97)Listen
8/8/2018Q2 2018($0.78)($0.85)($0.85)N/A
5/9/2018Q1 2018($0.81)($0.74)($0.74)N/A
3/8/2018Q4 2017($0.91)($0.82)($0.82)Transcript
11/14/2017Q3 2017($0.88)($0.88)($0.88)N/A
8/10/2017Q2 2017($0.77)($0.87)($0.87)N/A
5/11/2017Q1 2017($0.92)($0.83)($0.83)N/A
3/9/201712/31/2016($0.75)($0.91)($0.91)N/A
11/10/2016Q3 2016($0.66)($0.94)($0.94)N/A
8/31/2016Q2 2016($1.35)($6.43)($6.43)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.